a rapid mekc method for the simultaneous determination of creatinine, 1- and 3-methylhistidine in...
TRANSCRIPT
Short Communication
A rapid MEKC method for the simultaneousdetermination of creatinine, 1- and3-methylhistidine in human urine
The present report describes the use of MEKC in the presence of 35 mM sodium
tetraborate, pH 9.0, containing 60 mM SDS for the complete separation and identifica-
tion of creatinine, 1-methylhistidine (1-MeH) and 3-MeH in human urine. Their
simultaneous quantification in urine of healthy controls and subjects submitted to
elective surgery to their lower limbs allowed to use 3-MeH as a reliable measure of
skeletal protein breakdown. Simplicity, sensitivity and low running costs are the main
advantages of this method that is suitable for the routine analysis in clinical laboratories
of a large number of samples per day.
Keywords:
Creatinine / MEKC / 3-Methylhistidine / Urine DOI 10.1002/elps.200800565
Methylation of histidine molecule in the 1- and 3-positions
of the imidazole ring, with formation of 1-methylhistidine
(1-MeH) and 3-MeH, respectively [1–4], is a well-known
post-translational modification of actin and myosin.
Although skeletal muscle accounts for 90% of the total-
body 3-MeH pool, significant amounts of this amino acid
are also produced by the hydrolysis of ingested muscle
protein. This prevents the potential use of its excretion rate
in urine (3-MeH released after protein degradation in fact
can neither be re-used for protein synthesis nor metabo-
lized) as an index of muscle protein breakdown, unless the
amount derived from diet is known [5–10]. Interestingly, the
determination of 1-MeH meets this demand. Although
1-MeH is common in other animals, it is not produced in
humans. Given that its urinary levels correlate well with
those of exogenous 3-MeH, the simultaneous determination
of these amino acids becomes a reliable tool to monitor
proteolysis of the skeletal muscle proteins [11].
Although a direct fluorimetric method has already been
described [12], measurement is usually performed either by
ion-exchange chromatography or high-performance liquid
chromatography [8]. More recently, Tuma et al. [13, 14]
applied CZE to enhance sensitivity and to avoid time-
consuming pre-treatment procedures. However, if this
approach was fast and sensitive, it did not provide excellent
resolution of the two analytes [13]. On the other hand, the
development of this procedure by applying contactless
conductivity detection, while improving separation, consid-
erably lowered sensitivity [14].
This report demonstrates that MEKC provides an
excellent resolution coupled to high sensitivity and fast
analysis times and hence may satisfy all of these demanding
criteria.
Analyses were performed on a P/ACE (Beckman
Coulter, Fullerton, USA) model 5000 instrument equipped
with a UV detection system. Untreated fused-silica capil-
laries Beckman (50 mm id� 57 cm total length, 50 cm to the
detector) were used. An aliquot of 35 mM sodium tetra-
borate, pH 9.0, containing 60 mM SDS was the BGE.
Separations were carried out at 251C by applying a voltage of
20 kV. Aliquots containing 5–8 nL of sample were intro-
duced in the capillary under a nitrogen pressure of 3.5 kPa
for 5 s and the analytes monitored at 214 nm. Between runs,
the capillary was washed for 2 min with 0.5 N NaOH solu-
tion. MS spectra were produced by using an ESI-Ion Trap
model LCQ Advantage (Thermo Finnigan, San Jose, CA,
USA) equipment.
The separation of standard analytes showed the typical
pattern recorded in profile ‘‘a’’ of Fig. 1A in which peaks
numbered 1 (migration time, tm: 5.2370.20 min),
2 (tm: 6.6570.25 min) and 3 (tm: 7.9470.22 min) represent
creatinine, 1- and 3-MeH, respectively. Calibration curves
(data not shown) of the three standard compounds were
produced by measuring (in triplicate) over a concentration
range between 10 and 0.005 mM. The correlation coefficient
(r2) was 0.9990 for creatinine, and 0.9980 and 0.9975 for
1- and 3-MeH, respectively. The LOD, defined as three times
the signal-to-noise ratio, was 10 mM for creatinine and 5 mM
for the other two analytes. The intra-day and inter-day
precision (RSD%) of the MEKC system was examined for
variations in tm and peak area/corrected peak area (A/cA in
which cA 5 A/tm) of the analytes’ peaks. The intra-day
Fabio Ferrari1
Marco Fumagalli1
Simona Viglio1
Roberto Aquilani2
Evasio Pasini3
Paolo Iadarola1
1Department of Biochemistry ‘‘A.Castellani’’, University of Pavia,Pavia, Italy
2Metabolic Service andNutritional Pathophysiology,Salvatore Maugeri Foundation,Montescano, Pavia, Italy
3Cardiology Division, SalvatoreMaugeri Foundation, Gussago,Brescia, Italy
Received September 2, 2008Revised November 25, 2008Accepted November 25, 2008
Abbreviation: MeH, methylhistidine
Correspondence: Professor Paolo Iadarola, Dipartimento diBiochimica ‘‘A. Castellani’’, Universita di Pavia, Via Taramelli3/B I-27100 Pavia, ItalyE-mail: [email protected]: 139-0382-423108
& 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.electrophoresis-journal.com
Electrophoresis 2009, 30, 654–656654
precision was calculated by performing (in triplicate) ten
injections (n 5 30) of a mixture containing the compounds
at a concentration of 0.5 mM each. The inter-day precision
was determined by performing (in triplicate) four injec-
tions/day of this mixture over four consecutive days, for
a total of 48 injections.
The values calculated for intra- and inter-day precision
of migration times (ranging between 1.14 and 1.27 and
between 1.20 and 1.34 RSD %, respectively) confirmed the
stability of the system. Furthermore, intra-day precision of
corrected area values ranged between 0.94 and 1.13 and
inter-day precision between 1.05 and 1.30 RSD %. Accuracy,
calculated as the difference in concentration between
measured and theoretical, provided recovery values for the
three analytes ranging between 96.7 and 99%. The robust-
ness of the method was assessed performing experiments in
which a series of operational parameters including BGE
(50 mM sodium phosphate containing 60 mM SDS), injec-
tion volume (2.5 or 10 mL) and inner diameter of the capil-
lary (75 or 100 mm id) were varied. Results (data not shown)
confirmed that resolution and recovery of analytes were
practically identical to those achieved using the conditions
described above. Thus, given the good reliability of this
procedure, we proceeded to apply it to real samples.
Figure 1. (A) Profiles obtained by sub-mitting to electrophoretic separation: amixture of standard analytes (trace a), arepresentative urine sample chosen atrandom from all those investigated(trace b) and the same sample as intrace b, spiked with a known amount(1 mM final concentration) of a mixturecontaining the three standards (trace c).Peaks 1–3 in all traces represent creati-nine, 1- and 3-MeH, respectively.Separations were performed by using35 mM sodium tetraborate pH 9.0containing 60 mM SDS as the BGE andby applying a voltage of 20 kV. (B) MSspectra obtained from peaks 1–3collected performing a series (n 5 150)of ‘‘preparative’’ runs. The typical signalat m/z 5 114.06 corresponds to the[M1H]1 ion of creatinine; the signals atm/z 5 170.02 and 170.06 correspond tothe [M1H]1 ions of 1- and 3-MeH,respectively.
Electrophoresis 2009, 30, 654–656 CE and CEC 655
& 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.electrophoresis-journal.com
A total of 44 urine samples, 18 of which were from
healthy volunteers (controls) and 26 from patients who had
been submitted for elective surgery to their lower limbs (hip
and knee arthroprotesis, 12 and 14 patients, respectively),
were analyzed in triplicate without being submitted for any
pre-treatment procedure. Given the identity of profiles of
controls and patients, electropherogram shown in trace ‘‘b’’
of Fig. 1A may be considered representative of all available.
This pattern contained, in addition to others, three peaks
(numbered 1–3) whose migration times (tm: 5.2270.22,
6.6470.26 and 7.9570.22 min) corresponded exactly to
those of standard compounds (see values reported above).
To confirm their identity, a number (n 5 25) of urine
samples were spiked with a known amount (5 mL of a
10 mM solution; final concentration in the sample 1 mM
each) of standards and re-injected. As shown in trace ‘‘c’’ of
Fig. 1, which shows a typical pattern of spiked samples, the
perfect overlap of reference compounds peaks with those of
endogenous analytes promoted in co-injected samples a
proportional increase in the height of peaks numbered 1–3.
However, since the criterion of spiking samples with the
appropriate standard and monitoring their peak co-migra-
tion does not exclude the possibility that other components
of urine may co-elute with the spiked standards, MS
was used to assign unambiguously the peaks to the
above-mentioned analytes. This analysis was carried out
(i) performing a series (n 5 150) of ‘‘preparative’’ runs,
(ii) collecting the material hypothetically corresponding to
these analytes and (iii) submitting it to MS analysis. As
shown in Fig. 1B, the typical MS signals (m/z 5 114.06
corresponded to the [M1H]1 ion of creatinine;
m/z 5 170.02 and 170.06 corresponded to the [M1H]1 ions
of 1- and 3-MeH, respectively) not only confirmed the identity
of analytes but also assessed the absence of contaminants. As
deduced by our calculations, the amount of 3-MeH excreted
in urine by the two groups was apparently similar, the mean
values being 0.1170.05 and 0.1870.04 mm/mL for controls
and patients, respectively. However, the simultaneous deter-
mination of 1-MeH (corresponding to the amount of
exogenous 3-MeH) and of creatinine allowed to estimate that
the percent of muscle protein degraded each day by the group
of patients was three times higher than that of controls. The
application of the expression previously reported by Ballard
and Tomas [8] produced a mean value of muscular degra-
dation (%) of 2.20 for the subjects of the former group against
a value of 0.8 for those of the latter.
Although not surprising, given the important metabolic
alterations experienced by patients, this finding was of great
interest since it confirmed the reliability of the method in
revealing significant differences in the amount of muscle
degraded by individuals under different clinical conditions.
In conclusion this procedure seems to be a viable
alternative to existing methods. Given its simplicity, sensi-
tivity and low running costs, it is suitable for routine
analysis in clinical practice of a large number of urine
samples.
The authors thank Mr. Giuseppe Zucchinali (BeckmanCoulter, Milan, Italy) for his friendly co-operation with the CEequipments and Dr. Robert Coates (Centro Linguistico,Universita Bocconi, Milan, Italy) for his linguistic corrections.
The authors have declared no conflict of interest.
References
[1] Meister, A., Biochemistry of the Amino Acids, 2nd Edn.,Academic Press Inc., New York 1965.
[2] Johnson, P., Harris, C. I., Perry, S. V., Biochem. J. 1967,108, 79–80.
[3] Johnson, P., Harris, C. I., Perry, S. V., Biochem. J. 1967,105, 361–370.
[4] Asatoor, A. M., Armstrong, M. D., Biochem. Biophys.Res. Commun. 1967, 26, 168–174.
[5] Long, C. L., Haverberg, L. N., Young, V. R., Kinney, J. M.et al., Metabolism 1975, 24, 929–935.
[6] Young, V. R., Alexis, S. D., Baliga, B. S., Munro, H. N.,Muecke, W., J. Biol. Chem. 1972, 247, 3592–3600.
[7] Young, V. R., Munro, H. N., Fed. Proc. 1978, 37,2291–2300.
[8] Ballard, F. J., Tomas, F. M., Clin. Sci. 1983, 65,209–215.
[9] Sjolin, J., Hjort, G., Friman, G., Hambraeus, L., Meta-bolism 1987, 36, 1175–1184.
[10] Betto, P., Ricciarello, G., Pichini, S., Dello Strologo, L.,Tizzoni, G., J. Chromatogr. 1992, 584, 256–260.
[11] Goldsmith, R. F., Earl, J. W., Cunningham, A. M., Clin.Chem. 1987, 33, 1736–1740.
[12] Murray, A. J., Ballard, F. J., Tomas, F. M., Anal.Biochem. 1981, 116, 537–544.
[13] Tuma, P., Samcova, E., Balınova P., J. Chromatogr. B2005, 821, 53–59.
[14] Tuma, P., Samcova, E., Opekar, F., Jurka V., Stulik, K.,Electrophoresis 2007, 28, 2174–2180.
Electrophoresis 2009, 30, 654–656656 F. Ferrari et al.
& 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.electrophoresis-journal.com